Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News Avacta Group (AIM: AVCT) claims preCISION payload delivery shows structural advantages over ADCs as AVA6103 nears clinic Avacta Group plc releases new data claiming preCISION delivery advantages over ADCs as AVA6103 prepares to enter clinical trials. Read more. byVenkateshFebruary 24, 2026